Healthcare -
Biotechnology - NASDAQ - US
$ 5.25
8.25 %
$ 111 M
Market Cap
-0.96
P/E
ENTA - LONG-TERM DEBT
Long-term Debt ENTA - Enanta Pharmaceuticals, Inc.
53.9 M
LAST VALUE
55.28%
2 YEAR CAGR
206.32%
5 YEAR CAGR
0.00%
10 YEAR CAGR